Paraxanthine

Paraxanthine

SCHEMBL232702

Cn1c(=O)[nH]c2ncn(C)c2c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 1.00
▸ PMP22 Q01453 2/20 1.00
▸ ALDH1A1 P00352 2/20 1.00
▸ LMNA P02545 1/20 1.00
▸ MAPT P10636 1/20 1.00
▸ TSHR P16473 1/20 1.00
▸ BLM P54132 1/20 1.00
▸ GDA Q9Y2T3 2/20 0.56
▸ MAPK1 P28482 1/20 0.54
▸ ADORA2A P29274 5/20 0.50
▸ ADORA2B P29275 4/20 0.50
▸ PIK3CD O00329 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.49
▸ CNR1 P21554 1/20 0.49
▸ ACHE P22303 1/20 0.49
▸ ADORA1 P30542 1/20 0.49
▸ NTSR1 P30989 1/20 0.49
▸ MC3R P41968 1/20 0.49
▸ NOTUM Q6P988 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Paraxanthine SCHEMBL31604157 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL31604159 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL31604158 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL25323417 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL25322121 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL25320267 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL25323945 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL25320927 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL31604160 0.98 CYP3A4 (0.96) CYP3A4PMP22ALDH1A1LMNAMAPT
Paraxanthine SCHEMBL13384584 0.90 CYP3A4 (0.81) CYP3A4PMP22ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2852 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 — — EP claimed
WO-2026100654-A1 NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD 株式会社インファーマシア 2026-05-15 — — WO claimed
EP-4739285-A1 DISSOLVABLE ORALLY ADHERING TABLET Fertin Pharma A/S (DK) 2026-05-13 — — EP claimed
EP-4739147-A1 COMPOSITION Nicoventures Trading Limited (GB) 2026-05-13 — — EP claimed
WO-2026089413-A1 NUCLEATING AGENT FOR BIODEGRADABLE RESIN AND BIODEGRADABLE RESIN COMPOSITION COMPRISING SAME 씨제이제일제당(주) 2026-04-30 — — WO claimed
WO-2026090582-A1 COMPOSITIONS CONTAINING A NON-XANTHINE CNS STIMULANT OR NOOTROPIC AND BETA-HYDROXYBUTYRATE OR PRECURSOR FOR INCREASING NEUROLOGICAL AND PHYSIOLOGICAL PERFORMANCE AXCESS GLOBAL SCIENCES, LLC (US) 2026-04-30 — — WO claimed
US-20260108457-A1 THERMAL ENERGY SYSTEM FOR ADMINISTERING ACTIVE AGENTS ULTRAORAL LTD. (IL) 2026-04-23 — — US claimed
US-20260062414-A1 NOVEL COCRYSTALS OF METHYLXANTHINES, THEIR POLYMORPHS AND PROCESS THEREOF FERTIS INDIA PVT LTD (IN) 2026-03-05 — — US claimed
EP-4696298-A2 PERSONAL CLEANSING COMPOSITION Byrne, Daniel (IE) 2026-02-18 — — EP claimed
EP-4680228-A2 OPHTHALMIC CREAM FORMULATIONS AND THEIR USES Glaukos Corporation (US) 2026-01-21 — — EP claimed
EP-0167566-A4 ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME. SUNSHINE ABRAHAM (US) 1987-06-29 — — EP claimed
EP-0165308-A4 ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME. RICHARDSON VICKS INC (US) 1986-05-16 — — EP claimed
US-4567183-A SYNERGISTIC, POTENTIATION ANALGESIC ASSOCIATES (US) 1986-01-28 — — US claimed
EP-0167566-A1 ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME SUNSHINE, Abraham (US) 1986-01-15 — — EP claimed
EP-0165308-A1 ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME. RICHARDSON VICKS INC (US) 1985-12-27 — — EP claimed
US-4558051-A Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same RICHARDSON-VICKS, INC. (US) 1985-12-10 — — US claimed
EP-0019165-B1 PROCESS FOR PREPARING 1,3,7-TRIALKYLXANTHINES SOCIETE DES PRODUITS NESTLE S.A. (CH) 1985-07-31 — — EP claimed
WO-1985002540-A1 ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME RICHARDSON-VICKS, INC. (US) 1985-06-20 — — WO claimed
WO-1985002542-A1 ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME SUNSHINE ABRAHAM 1985-06-20 — — WO claimed
US-4450163-A ANTIBODY INHIBITORS; N-ALKYLATION OF XANTHINES USING PHASE TRANSFER AGENTS SOCIETE D'ASSISTANCE TECHNIQUE POUR PRODUITS NESTLE S.A. (CH) 1984-05-22 — — US claimed
Send feedback